Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients.

Autor: Wang JZ; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada., Landry AP; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada., Raleigh DR; Department of Radiation Oncology, Neurological Surgery, and Pathology, University of California San Francisco, San Francisco, California, USA., Sahm F; Department of Neuropathology, University Hospital Heidelberg and German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Walsh KM; Department of Neurosurgery, Duke University, Durham, North Carolina, USA., Goldbrunner R; Center of Neurosurgery, Department of General Neurosurgery, University of Cologne, Cologne, Germany., Yefet LS; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada., Tonn JC; Department of Neurosurgery, University Hospital Munich LMU, Munich, Germany., Gui C; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada., Ostrom QT; Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Central Brain Tumor Registry of the United States, Hinsdale, Illinois, USA.; Department of Neurosurgery, Duke University, Durham, North Carolina, USA., Barnholtz-Sloan J; Center for Biomedical Informatics & Information Technology (CBIIT), National Cancer Institute, Bethesda, Maryland, USA.; Trans Divisional Research Program (TDRP), Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute, Bethesda, Maryland, USA.; Central Brain Tumor Registry of the United States, Hinsdale, Illinois, USA., Perry A; Department of Pathology, University of California San Francisco, San Francisco, California, USA., Ellenbogen Y; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada., Hanemann CO; Peninsula Schools of Medicine, University of Plymouth University, Plymouth, UK., Jungwirth G; Division of Experimental Neurosurgery, Department of Neurosurgery, Heidelberg University, Heidelberg, Germany., Jenkinson MD; Department of Neurosurgery, The Walton Centre NHS Foundation Trust, Liverpool, UK.; Institute of Translational Medicine, University of Liverpool, UK., Tabatabai G; Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany.; Cluster of Excellence (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies,' Eberhard Karls University Tübingen, Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Tübingen, Germany., Mathiesen TI; Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., McDermott MW; Division of Neuroscience, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida, USA.; Miami Neuroscience Institute, Baptist Health of South Florida, Miami, Florida, USA., Tatagiba M; Department of Neurosurgery, University of Tübingen, Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Tübingen, Germany., la Fougère C; Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tübingen, Germany.; Cluster of Excellence (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies,' Eberhard Karls University Tübingen, Tübingen, Germany., Maas SLN; Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Galldiks N; Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Institute of Neuroscience and Medicine (IMN-3), Research Center Juelich, Juelich, Germany., Albert NL; Department of Nuclear Medicine, Ludwig Maximilians-University of Munich, Munich, Germany., Brastianos PK; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., Ehret F; Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health, Charité - Universitätsmedizin Berlin, Berlin, Germany., Minniti G; Department of Radiological Sciences, Oncology and Anatomical Pathology, Sapienza University of Rome, Rome, Italy., Lamszus K; Laboratory for Brain Tumor Biology, University Hospital Eppendorf, Hamburg, Germany., Ricklefs FL; Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Schittenhelm J; Department of Neuropathology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Tübingen, Germany., Drummond KJ; Department of Neurosurgery, The Royal Melbourne Hospital, Melbourne, Victoria, Australia., Dunn IF; Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA., Pathmanaban ON; Division of Neuroscience and Experimental Psychology, Manchester Centre for Clinical Neurosciences, Geoffrey Jefferson Brain Research Centre, University of Manchester, Manchester, UK., Cohen-Gadol AA; Department of Neurological Surgery, Indiana University, Indianapolis, Indiana, USA., Sulman EP; Department of Radiation Oncology, NYU Grossman School of Medicine, New York, New York, USA., Tabouret E; CNRS, INP, Inst Neurophysiopathol, Aix-Marseille University, Marseille, France., Le Rhun E; Department of Neurology & Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland., Mawrin C; Department of Neuropathology, University Hospital Magdeburg, Magdeburg, Germany., Moliterno J; Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut, USA., Weller M; Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland., Bi WL; Department of Neurosurgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Gao A; Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto, Ontario, Canada., Yip S; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Radiation Oncology, University Hospital, Munich, Germany.; German Cancer Consortium (DKTK), Munich, Germany., Niyazi M; Bavarian Cancer Research Center (BZKF), Munich, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Tübingen, Germany., Aldape K; Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Wen PY; Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Short S; Leeds Institute of Medical Research, St James's University Hospital, Leeds, UK., Preusser M; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Nassiri F; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada., Zadeh G; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.

Publikováno v: Neuro-oncology [Neuro Oncol] 2024 Oct 03; Vol. 26 (10), pp. 1742-1780.

Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas.

Autor: Wang JZ; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Patil V; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Liu J; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Dogan H; Department of Neuropathology, University Hospital Heidelberg (DKFZ), Heidelberg, Germany., Tabatabai G; German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, Tübingen, Germany.; Cluster of Excellence (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University Tübingen, Tübingen, Germany.; Department of Neurology and Interdisciplinary Neuro-Oncology, Center for Neuro-Oncology, Comprehensive Cancer Center, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany., Yefet LS; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada., Behling F; Department of Neurosurgery, Center for Neuro-Oncology, Comprehensive Cancer Center, Eberhard Karls University Tübingen, Tübingen, Germany., Hoffman E; Cluster of Excellence (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University Tübingen, Tübingen, Germany., Bunda S; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Yakubov R; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Kaloti R; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Brandner S; Division of Neuropathology, UCL Queen Square Institute of Neurology, London, UK., Gao A; Division of Laboratory Medicine and Pathobiology, University Health Network, Toronto, ON, Canada., Cohen-Gadol A; Department of Neurosurgery, Indiana University, Bloomington, IND, USA., Barnholtz-Sloan J; Division of Cancer Epidemiology and Genetics, Center for Biomedical Informatics and Information Technology, National Cancer Institute, National Institutes of Health, Gaithersburg, MD, USA., Skardelly M; Department of Neurology and Interdisciplinary Neuro-Oncology, Center for Neuro-Oncology, Comprehensive Cancer Center, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany., Tatagiba M; Department of Neurosurgery, Center for Neuro-Oncology, Comprehensive Cancer Center, Eberhard Karls University Tübingen, Tübingen, Germany., Raleigh DR; Department of Radiation Oncology, Neurological Surgery, and Pathology, University of California San Francisco, San Francisco, CA, USA., Sahm F; Department of Neuropathology, University Hospital Heidelberg (DKFZ), Heidelberg, Germany., Boutros PC; Department of Human Genetics, University of California Los Angeles (UCLA), Los Angeles, CA, USA., Aldape K; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Nassiri F; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada. farshad.nassiri@mail.utoronto.ca.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada. farshad.nassiri@mail.utoronto.ca.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. farshad.nassiri@mail.utoronto.ca., Zadeh G; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada. gelareh.zadeh@uhn.ca.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada. gelareh.zadeh@uhn.ca.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. gelareh.zadeh@uhn.ca.

Publikováno v: Acta neuropathologica [Acta Neuropathol] 2023 Jul; Vol. 146 (1), pp. 171-172.

Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.

Autor: Nassiri F; Division of Neurosurgery, University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Patil V; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Yefet LS; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Singh O; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Liu J; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Dang RMA; Department of Human Genetics, University of California Los Angeles, Los Angeles, CA, USA., Yamaguchi TN; Department of Human Genetics, University of California Los Angeles, Los Angeles, CA, USA., Daras M; Division of Neuro-oncology, University of California San Francisco, San Francisco, CA, USA., Cloughesy TF; UCLA Neuro-Oncology Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Colman H; Huntsman Cancer Institute and Department of Neurosurgery, University of Utah, Salt Lake City, UT, USA., Kumthekar PU; Department of Neurology, Division of Neuro-Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Chen CC; Department of Neurosurgery, University of Minnesota, Minneapolis, MI, USA., Aiken R; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA., Groves MD; Department of Neurology, Texas Oncology, Austin, TX, USA., Ong SS; Division of Neuro-Oncology, Department of Neurology, the Ohio State University Wexner Medical Center, Columbus, Ohio, USA., Ramakrishna R; Department of Neurological Surgery, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA., Vogelbaum MA; Department of Neuro-Oncology, Neuro-Oncology Program, Moffitt Cancer Center, Tampa, FL, USA., Khagi S; Division of Medical Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Kaley T; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Melear JM; Department of Internal Medicine, Baylor University Medical Center, Dallas, TX, USA., Peereboom DM; The Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH, USA., Rodriguez A; Department of Neurosurgery, University of Arkansas for Medical Sciences, Little Rock, AK, USA., Yankelevich M; Department of Pediatrics, University of Michigan, Ann Arbor Beaumont Children's Hospital, Royal Oak, MI, USA., Nair SG; Lehigh Valley Topper Cancer Institute, Allentown, PA, USA., Puduvalli VK; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Aldape K; Laboratory of Pathology, National Cancer Institute, Bethesda, MD, USA., Gao A; Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto, Ontario, Canada., López-Janeiro Á; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdISNA), Pamplona, Spain., de Andrea CE; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdISNA), Pamplona, Spain., Alonso MM; Navarra Institute for Health Research (IdISNA), Pamplona, Spain.; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Program of Solid Tumors, Center for the Applied Medical Research (CIMA), Pamplona, Spain., Boutros P; Department of Human Genetics, University of California Los Angeles, Los Angeles, CA, USA., Robbins J; DNATrix Inc., Carlsbad, CA, USA., Mason WP; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Sonabend AM; Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.; Northwestern Medicine Malnati Brain Tumor Institute of the Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Stupp R; Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.; Northwestern Medicine Malnati Brain Tumor Institute of the Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.; Department of Medicine, Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.; Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Fueyo J; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gomez-Manzano C; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lang FF; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zadeh G; Division of Neurosurgery, University of Toronto, Toronto, Ontario, Canada. gelareh.zadeh@uhn.ca.; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada. gelareh.zadeh@uhn.ca.; Department of Surgery, University of Toronto, Toronto, Ontario, Canada. gelareh.zadeh@uhn.ca.

Publikováno v: Nature medicine [Nat Med] 2023 Jun; Vol. 29 (6), pp. 1370-1378. Date of Electronic Publication: 2023 May 15.

Shoulder Rotation Function Following the Sup-ER Protocol in Children with Brachial Plexus Injuries.

Autor: Yefet LS; University of British Columbia, Vancouver, Canada.; British Columbia Children's Hospital, Vancouver, Canada., Bellows D; University of British Columbia, Vancouver, Canada.; British Columbia Children's Hospital, Vancouver, Canada., Bucevska M; University of British Columbia, Vancouver, Canada.; British Columbia Children's Hospital, Vancouver, Canada., Courtemanche R; University of British Columbia, Vancouver, Canada.; British Columbia Children's Hospital, Vancouver, Canada., Durlacher K; University of British Columbia, Vancouver, Canada.; British Columbia Children's Hospital, Vancouver, Canada., Hynes S; University of British Columbia, Vancouver, Canada.; British Columbia Children's Hospital, Vancouver, Canada., Verchere C; University of British Columbia, Vancouver, Canada.; British Columbia Children's Hospital, Vancouver, Canada.

Publikováno v: Hand (New York, N.Y.) [Hand (N Y)] 2022 May; Vol. 17 (3), pp. 549-557. Date of Electronic Publication: 2020 Jul 16.

Sex differences in surgically correctable congenital anomalies: A systematic review.

Autor: Black AJ; Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Lu DY; Department of Surgery, University of British Columbia, Vancouver, BC, Canada., Yefet LS; Department of Surgery, University of British Columbia, Vancouver, BC, Canada., Baird R; Division of Pediatric Surgery, Department of Surgery, University of British Columbia, Vancouver, BC, Canada. Electronic address: robert.baird@cw.bc.ca.

Publikováno v: Journal of pediatric surgery [J Pediatr Surg] 2020 May; Vol. 55 (5), pp. 811-820. Date of Electronic Publication: 2020 Feb 12.